Meibomian gland related parameters in patients with benign hyperplastic prostata (BPH)

MGD in BPH - MGD in BPH

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036352

Enrollment

200

Registered

2019-04-01

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hypertrophy

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with anti-BPH drugs

Exclusion criteria

Exclusion criteria: Acute inflammation diseases

Design outcomes

Primary

Measure	Time frame
meibography score, lid margin score, BUT, meibum grade, SPK, tear meniscus height, Schirmer	—

Countries

Japan

Contacts

Public ContactReiko Arita

Itoh Clinic Ophthalmology

ritoh@za2.so-net.ne.jp+81486865588

Outcome results